Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BMP1 | P13497 | 3/20 | 0.51 |
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.39 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.39 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.39 |
| ▸ | GNPAT | O15228 | 1/20 | 0.37 |
| ▸ | ANPEP | P15144 | 1/20 | 0.37 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.37 |
| ▸ | DPP4 | P27487 | 2/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.35 |
| ▸ | TASP1 | Q9H6P5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15202797 | 0.92 | BMP1 (0.49) | BMP1SIRT5FOLH1NAALAD2RIMKLA | |
| SCHEMBL13377665 | 0.92 | BMP1 (0.49) | BMP1SIRT5FOLH1NAALAD2RIMKLA | |
| SCHEMBL14685778 | 0.91 | BMP1 (0.46) | BMP1SIRT5FOLH1NAALAD2RIMKLA | |
| SCHEMBL17192782 | 0.89 | SIRT5 (0.50) | BMP1SIRT5FOLH1NAALAD2RIMKLA | |
| SCHEMBL14553975 | 0.87 | DPP4 (0.50) | BMP1SIRT5FOLH1NAALAD2RIMKLA | |
| SCHEMBL17880375 | 0.87 | DPP4 (0.50) | BMP1SIRT5FOLH1NAALAD2RIMKLA | |
| SCHEMBL14553986 | 0.85 | BMP1 (0.40) | BMP1SIRT5FOLH1GNPATDPP4 | |
| SCHEMBL14553989 | 0.85 | NAALAD2 (0.50) | NAALAD2GNPAT | |
| SCHEMBL26568534 | 0.84 | BMP1 (0.42) | BMP1SIRT5FOLH1NAALAD2RIMKLA | |
| SCHEMBL12018363 | 0.84 | BMP1 (0.44) | BMP1SIRT5GNPATDPP4DPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9101687-B2 | Beta sheet tapes ribbons in tissue engineering | UNIVERSITY OF LEEDS (GB) | 2015-08-11 | — | — | US | disclosed |
| US-20130012457-A1 | BETA SHEET TAPES RIBBONS IN TISSUE ENGINEERING | THE UNIVERSITY OF LEEDS | 2013-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130012457-A1 | BETA SHEET TAPES RIBBONS IN TISSUE ENGINEERING | IAPP, TAGLN2, KRT18 | BMP1 162/4885SIRT5 4799/4885FOLH1 1001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.